Suppr超能文献

根据(欧盟)第396/2005号法规第12条对精甲霜灵现有最大残留限量的审查。

Review of the existing maximum residue levels for benalaxyl-M according to Article 12 of Regulation (EC) No 396/2005.

作者信息

Anastassiadou Maria, Brancato Alba, Carrasco Cabrera Luis, Ferreira Lucien, Greco Luna, Jarrah Samira, Kazocina Aija, Leuschner Renata, Magrans Jose Oriol, Miron Ileana, Nave Stefanie, Pedersen Ragnor, Reich Hermine, Rojas Alejandro, Sacchi Angela, Santos Miguel, Stanek Alois, Theobald Anne, Vagenende Benedicte, Verani Alessia

出版信息

EFSA J. 2019 Sep 23;17(9):e05818. doi: 10.2903/j.efsa.2019.5818. eCollection 2019 Sep.

Abstract

According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance benalaxyl-M. To assess the occurrence of benalaxyl-M residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EU) No 188/2011, the European authorisations for benalaxyl-M reported by Member States (including the supporting residues data) and also the authorised uses of benalaxyl reviewed by EFSA in the past (as they may generate common residues with benalaxyl-M) and the MRLs established for benalaxyl by the Codex Alimentarius Commission. Based on the assessment of the available data, MRL proposals were derived and a consumer risk assessment was carried out. Although no apparent risk to consumers was identified, some information required by the regulatory framework was missing. Hence, the consumer risk assessment is considered indicative only and all MRL proposals derived by EFSA still require further consideration by risk managers.

摘要

根据欧盟法规(EC)No 396/2005第12条,欧洲食品安全局(EFSA)审查了目前在欧洲层面为农药活性物质精甲霜灵设定的最大残留限量(MRLs)。为评估精甲霜灵在植物、加工产品、轮作作物和牲畜中的残留情况,EFSA考虑了欧盟委员会法规(EU)No 188/2011框架下得出的结论、成员国报告的精甲霜灵欧洲授权(包括支持性残留数据),以及EFSA过去审查的精甲霜灵的授权用途(因为它们可能与精甲霜灵产生共同残留)和食品法典委员会为甲霜灵设定的MRLs。在对现有数据进行评估的基础上,得出了MRL建议并进行了消费者风险评估。尽管未发现对消费者有明显风险,但监管框架要求的一些信息缺失。因此,消费者风险评估仅被视为指示性的,EFSA得出的所有MRL建议仍需风险管理者进一步考虑。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验